Liz was a PhD student funded by an Alzheimer’s Society studentship. Her work investigated how different neuroimaging techniques could be used to improve the quality of clinical trials in FTD. She had previously undertaken a BSc in Cognitive Neuroscience at the University of Melbourne in Australia, and an MSc in Clinical and Experimental Medicine at UCL. She completed her PhD in 2020.
- 11th ICFTD (Sydney, November 2018): Comparison of automated segmentation tools in FTD: Implications for imaging biomarker choice in clinical trials.
- 11th ICFTD (Sydney, November 2018): Comparison of automated segmentation tools in FTD: Implications for imaging biomarker choice in clinical trials
- 10th ICFTD (Munich, September 2016): Clinical, genetic and pathological stratification in FTD: implications for clinical trial design
- ARUK Conference 2016 (Manchester, March 2016): Phenomenology and anatomy of abnormal behaviours in FTD as measured by the Cambridge Behavioural Inventory
- AAIC 2015 (Washington, July 2015): A cross-sectional and longitudinal investigation of the CBI-R in bvFTD
- 9th ICFTD (Vancouver, October 2014): Longitudinal pattern of cortical thinning in bvFTD
- A comparison of automated atrophy measures across the frontotemporal dementia spectrum: Implications for trials. Gordon E, Bocchetta M, Nicholas J, Cash DM, Rohrer JD. Neuroimage Clin. 2021
- Advances in neuroimaging in frontotemporal dementia. Gordon E, Rohrer JD, Fox NC. J Neurochem. 2016;138 Suppl 1:193-210.
